Director, US Real-World Evidence and Health Outcomes – Non Small Cell Lung Cancer (NSCLC)
GSK plc - 3 Locations
Posted Nov 5, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- Not verified
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Role
- Seniority
- Director Plus From the posting source checked Nov 16, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Director, US Real-World Evidence and Health Outcomes – Non Small Cell Lung Cancer (NSCLC) 3 Locations Director, US Real-World Evidence and Health Outcomes - Non Small Cell Lung Cancer (NSCLC) Office-based: Philadelphia, PA or Durham, NC; travel as required (typically up to ~20%). Reports to: Sr. Director and Head, US RWE/HO Oncology Role Summary: The role of Director, US Real-World Evidence & Health Outcomes Research Scientist Hematology-Oncology ensures that each medicine GSK brings to market is supported by scientifically credible, high quality evidence that drives competitiveness and strong evidence-based product positioning, value propositions, and value-based pricing. The role is accountable for developing and delivering components of the US data generation plan (including RWE and economic value evidence), ensuring strategic alignment across key internal stakeholders (US Medical, Commercial/Market Access, Global RWE & HO, Global Medical Affairs, R&D Epidemiology and Clinical Development), and driving high-quality deliverables that inform internal decision-making during product development, pre-launch readiness, and lifecycle planning. This role promises a fast-paced environment supporting a new-to-market product in a dynamic hematology space. Key Responsibilities: Evidence strategy and planning: Implementation of RWE/HO research by developing evidence generation plan and designing multiple RWE/HO studies, aligned to US medical, payer, and access needs; translate strategy into actionable workplans, timelines, and resourcing proposals. Translate needs for evidence into study concepts in alignment with strategic objectives and vision for the asset, e.g. development of study protocols and proposing innovative and cost-effective ways of developing and executing studies Study leadership (RWE/HEOR): Own day-to-day leadership for assigned real-world
Read the full description at gsk.wd5.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Director, Global Real-World Evidence & Health Outcomes Scientist, Oncology
GSK plc - 6 Locations
Principal Scientist (Director) - Outcomes Research - Lung Cancers
Merck & Co., Inc. - 2 Locations
Associate Director, Global Real-World Evidence, Oncology
Johnson & Johnson - Raritan, New Jersey, United States of America
Director, US Lung Market Research
Revolution Medicines - Redwood City, California, United States